{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:54:14Z","timestamp":1786866854469,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clml.2025.01.011","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:23:33Z","timestamp":1737678213000},"page":"e411-e416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-7817","authenticated-orcid":false,"given":"Erman","family":"Akkus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Tuncal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-8657","authenticated-orcid":false,"given":"Meral","family":"Beksac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2025.01.011_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.clml.2025.01.011_bib0002","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2025.01.011_bib0003","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2025.01.011_bib0004","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2025.01.011_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199809057562","article-title":"Multiple myeloma in young patients: clinical presentation and treatment approach","volume":"30","author":"Blad\u00e9","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2025.01.011_bib0006","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.clml.2025.01.011_bib0007","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.3390\/cancers13174385","article-title":"Familial risks and proportions describing population landscape of familial cancer","volume":"13","author":"Hemminki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clml.2025.01.011_bib0008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41375-019-0703-6","article-title":"Genetic predisposition for multiple myeloma","volume":"34","author":"Pertesi","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0009","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjh.19271","article-title":"Germline genetic variants in Turkish familial multiple myeloma\/monoclonal gammopathy of undetermined significance cases","volume":"204","author":"Akkus","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0010","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood.V95.5.1869.005k09_1869_1871","article-title":"Germline CDKN2A mutation implicated in predisposition to multiple myeloma","volume":"95","author":"Dilworth","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.01.011_bib0011","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/s41375-019-0452-6","article-title":"Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma","volume":"33","author":"Pertesi","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0012","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-17-1900","article-title":"Germline lysine-specific demethylase 1 (LSD1\/KDM1A) mutations confer susceptibility to multiple myeloma","volume":"78","author":"Wei","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2025.01.011_bib0013","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ejca.2005.11.033","article-title":"Familial risks and temporal incidence trends of multiple myeloma","volume":"42","author":"Altieri","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2025.01.011_bib0014","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.24514","article-title":"Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden","volume":"125","author":"Kristinsson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2025.01.011_bib0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/leu.2015.279","article-title":"Search for familial clustering of multiple myeloma with any cancer","volume":"30","author":"Frank","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.01.011_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.14199","article-title":"Multiple myeloma and family history of lymphohaematopoietic cancers: results from the International Multiple Myeloma Consortium","volume":"175","author":"Schinasi","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0018","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMc081677","article-title":"Familial myeloma","volume":"359","author":"Camp","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clml.2025.01.011_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ejh.13757","article-title":"Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: a population-based study","volume":"108","author":"Langseth","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12885-017-3715-5","article-title":"Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report","volume":"17","author":"Shah","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2025.01.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007111","article-title":"Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk","volume":"14","author":"Waller","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clml.2025.01.011_bib0022","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1002\/cncr.30777","article-title":"Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles","volume":"123","author":"Bolli","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2025.01.011_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41408-021-00422-6","article-title":"Characterization of rare germline variants in familial multiple myeloma","volume":"11","author":"Catalano","year":"2021","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2025.01.011_bib0024","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/cells12010096","article-title":"Investigation of rare non-coding variants in familial multiple myeloma","volume":"12","author":"Niazi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clml.2025.01.011_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/bloodadvances.2016003111","article-title":"Direct evidence for a polygenic etiology in familial multiple myeloma","volume":"1","author":"Halvarsson","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2025.01.011_bib0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2020-137337","article-title":"A prospective study and identification of genomewide association markers of familial predisposition to plasma cell dyscrasias","volume":"136","author":"Sperling","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.01.011_bib0027","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41375-023-02022-8","article-title":"Identification of novel genetic loci for risk of multiple myeloma by functional annotation","volume":"37","author":"Macauda","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0028","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S2152-2650(24)02097-4","article-title":"P-194 A germline variant of BNIP1 Gene (rs28199) is associated with familial multiple myeloma","volume":"24","author":"Akkus","year":"2024","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"10.1016\/j.clml.2025.01.011_bib0029","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ejhg.2011.57","article-title":"Gene set analysis of SNP data: benefits, challenges, and future directions","volume":"19","author":"Fridley","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clml.2025.01.011_bib0030","article-title":"Family affairs: dissecting inherited contributions to multiple myeloma risk","author":"Bodnar","year":"2024","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0031","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ajh.26785","article-title":"Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: a multicenter Intergroupe Francophone du My\u00e9lome study","volume":"98","author":"Dumontet","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ejh.12133","article-title":"Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma","volume":"91","author":"Greenberg","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0033","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41375-021-01454-4","article-title":"Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis","volume":"36","author":"Visram","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0034","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41375-018-0246-2","article-title":"Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics","volume":"33","author":"Clay-Gilmour","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1281412","article-title":"Nonrandom occurrence of lymphoid cancer types in 140 families","volume":"58","author":"Jones","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2025.01.011_bib0036","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1200\/JCO.2005.10.126","article-title":"Phenotypic heterogeneity in multiple myeloma families","volume":"23","author":"Lynch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.01.011_bib0037","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.1999.01415.x","article-title":"Familial multiple myeloma: report of fifteen families","volume":"105","author":"Grosbois","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2025.01.011_bib0038","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/2643-3230.BCD-23-0208","article-title":"Multiple myeloma risk and outcomes are associated with pathogenic germline variants in DNA repair genes","volume":"5","author":"Thibaud","year":"2024","journal-title":"Blood Cancer Discov"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T20:26:22Z","timestamp":1747686382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2152265025000217"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.01.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}